CIK 0001108205
- Non-accelerated filer
- Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043505116
- Phone
- +1 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 4/A Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO and Director acquired 25,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO and Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Exercise or conversion Director acquired 54,688 shares (option exercise)
- 4 Open-market sale VP, Tech Management sold 700 shares at $4.84 ($3,388)
- 4 Open-market sale VP, Tech Management sold 4,300 shares at an average $4.85 ($20,852)
- 4 Open-market sale Chief Executive Officer sold 17,900 shares at an average $4.51 ($80,651)
- 4 Open-market sale Chief Executive Officer sold 19,900 shares at an average $4.51 ($89,786)
Page 18 of 24 · 475 filings